Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
September 2002
Features
Pharmaceutical-Approval Update
New treatments for irritable bowel syndrome, erectile dysfunction, and postherpetic neuralgia
Marvin M. Goldenberg, PhD
The Cardiac Risks of Noncardiac Medications: Should You Make Formulary Changes?
The author discusses the effects of various drugs on the cardiac QTc interval.
Alan Hopefl, PharmD
Cover Story
Complementary/Alternative Medicine Use: Responsibilities and Implications for Pharmacy Services
The increasing use of complementary and alternative remedies presents a challenge to pharmacists as they strive to ensure rational drug therapy.
Kenneth R. Cohen, PhD, RPh, Peter Cerone, MS, RPh, and Robert Ruggiero, PharmD
Short-Term Cost-Effectiveness of Bisphosphonate Therapies for Postmenopausal Osteoporotic Women at High Risk of Fracture
The authors evaluated the budget impact of risedronate and alendronate
in the treatment of patients with postmenopausal osteoporosis.
D. T. Grima, MSc, R. T. Burge, PhD, D. L. Becker, MSc, and
A. N. A. Tosteson, ScD
Continuing Education
Principles for Managing Vaccine Shortages
The authors review vaccines included on the recommended childhood
immuzation schedule that are currently in short supply and propose
suggestions for tracking patients affected by vaccine shortages.
S. Jay Weaver, PharmD, and Paul L. Doering, MS Pharm
Guest Commentary
Monitoring Dietary Supplements and Medication Errors: USP Prescription for Safety
In an effort to inform and safeguard the growing number of consumers
who use dietary supplements, the U.S. Pharmacopeia (USP) has developed the Dietary Supplement Verification Program.
Miriam Reisman
Departments
Editorial
Prophylactic Ethics
Editor-in-Chief David Nash discusses “Prophylactic Ethics” in the age of genomics.
David B. Nash, MD, MBA
Drug News
New Drugs/Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA.
Medication Errors
Can You Afford to Omit CPOE In Future Strategic Plans?
Matthew Grissinger, RPh, discusses savings that can result from implementing CPOE systems.
Matthew Grissinger
Prescription Washington
Few Marketing Obstacles in DHHS Data Privacy Rule
DHHS sets marketing hurdle for PBMs.
Stephen Barlas
